Alexander Turchin MD MS, FACMI
Diabetes, Lipid Metabolism
Associate Professor of Medicine, Harvard Medical School
Join to View Full Profile
221 Longwood AvenueRfb 2Boston, MA 02115
Phone+1 617-732-5661
Dr. Turchin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alexander Turchin is an endocrinologist based in Boston, MA. He completed his fellowship in endocrinology, diabetes, and metabolism at Brigham and Women's Hospital and his residency in internal medicine at Tufts Medical Center. Dr. Turchin holds the positions of Director of Quality in Diabetes and Director of Informatics Research at the Division of Endocrinology at Brigham and Women's Hospital. His research interests include diabetes and other chronic cardiometabolic conditions as well as data science. Dr. Turchin is involved in clinical trials and has received several honors, including being named a Fellow of the American College of Medical Informatics.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2002 - 2005
Tufts Medical CenterResidency, Internal Medicine, 1999 - 2002
Johns Hopkins University School of MedicineClass of 1999
Certifications & Licensure
MA State Medical License 2001 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Fellow American College of Medical Informatics, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Efficacy of the Pre-Admission Medication List (PAML) Builder Reminder Prompts Start of enrollment: 2008 Apr 01
Publications & Presentations
PubMed
- 1 citationsCardiovascular Events in Individuals Treated With Sulfonylureas or Dipeptidyl Peptidase 4 Inhibitors.Alexander Turchin, Lucia C Petito, Emma Hegermiller, Ryan Carnahan, Andrea DeVries
JAMA Network Open. 2025-07-01 - Impact of Statin Nonacceptance on Cardiovascular Outcomes in Patients With Diabetes.Nisarg Shah, Zhou Lan, C Justin Brown, Seth S Martin, Alexander Turchin
Journal of the American Heart Association. 2025-06-03 - 1 citationsReasons for non-acceptance of statin therapy by patients at high cardiovascular risk.Minjia Xie, Seth S Martin, Alexander Turchin
Scientific Reports. 2025-05-16
Journal Articles
- Ambulatory Medication Reconciliation and Frequency of Hospitalizations and Emergency Department Visits in Patients with DiabetesAlexander Turchin, MD, Diabetes Care
Press Mentions
AI Offers Promise in Chronic Endocrine Disease ManagementAugust 1st, 2025- Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV RisksAugust 1st, 2025
- Glipizide Linked to Highest MACE-4 Risk in Individuals with Type 2 DiabetesJuly 29th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
